Biotechnology patents and morality

Trends in Biotechnology

Volumn 15, Issue 4, 1997, Pages 123-129

  Crespi, R Stephen ^a  

^a Blackbird Cottage   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RELAXIN;

ANIMAL; ARTICLE; BIOTECHNOLOGY; ETHICS; LAW; MICROORGANISM; MORALITY; PATENT; PLANT; PRIORITY JOURNAL;

EID: 0030892539     PISSN: 01677799     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-7799(97)01028-7     Document Type: Conference Paper

References (10)

1. Ministry of Agriculture, Fisheries and Food (1993) Report of the Committee on the Ethics of Genetic Modification and Food Use, Her Majesty's Stationery Office
2. Ministry of Agriculture, Fisheries and Food (1994) Report of the Committee to Consider the Ethical Implications of Emerging Technologies in the Breeding of Farm Animals, Her Majesty's Stationery Office
3. EC Directive Joint Text approved by Conciliation Committee 21 February 1995 PE-CONS 3606/1/95 REV 1
4. Relaxin, EP 112 149 (1991) published 10 April
5. Lord Adrian, President, Research Defence Society, at Royal Society Conference, London, 26 April 1991
6. EPI Information Bulletin 4/1993, European Patent Institute, Munich
7. Plant Genetic Systems, EP 242 236, Opposition Division Decision (1991) published 10 October
8. Nuffield Council on Bioethics, Nuffield Foundation
9. Council of Europe, Directorate of Legal Affairs (1994) Draft Convention for the Protection of Human Rights and Dignity of Human Beings with regard to the Application of Biology and Medicine: Bioethics Convention and Explanatory Report, Strasbourg
10. Vogel, F. and Grunwald, R., eds (1994) Patenting of Genes and Living Organisms, p. 135, Springer-Verlag